FLOW HIJACKED · PROFESSIONAL VIEW · LECTURE 48

Evidence map: Depression—When Reach Collapses

A contradiction-preserving map from symptom heterogeneity and circuit theory to the BA25 deep-brain-stimulation evidence sequence.

TWO DIMENSIONS, NOT ONE LADDER

Evidence strength and claim origin stay separate.

A strength badge describes the evidence base. An origin tag appears only when a claim is a cross-domain application, an original synthesis or lived-experience knowledge. Visible text—not colour—carries the meaning.

Established

Strong, consistent evidence, high-quality guidance or broad scientific consensus supports this claim.

Supported

Good evidence supports the claim, but important qualifications or limits remain.

Emerging

Promising evidence exists, but replication, larger samples or broader validation is still needed.

ONE COMPLETE TRACE

From the sentence on the site to its inference boundary.

01 · CLAIM

BROADEN did not erase the early remissions; it established that mechanistic promise and open improvement were insufficient to prove that SCC-DBS itself outperformed sham.

02 · SOURCE

Mayberg, H. S., Lozano, A. M., Voon, V. et al. · 2005Deep brain stimulation for treatment-resistant depression

03 · WHAT IT SUPPORTS

In an open six-person proof-of-concept study, four participants had sustained remission at six months.

04 · BOUNDARY

SCC-DBS for depression remains experimental. Mechanistic plausibility and open improvement must stay beside controlled negative evidence.

CLAIM MAP

Claim → source → use → boundary.

All records were last verified 2026-08-31. Every claim has a stable, directly linkable anchor.

Lecture 48 · Section 19 · One Label, 1,030 Profiles: Heterogeneity

In 3,703 participants entering STAR*D, Fried and Nesse identified 1,030 distinct symptom profiles; the most common appeared in only 1.8 percent.

Supported

KEY SOURCE · Direct evidence

Fried, E. I. & Nesse, R. M. (2015). Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. Journal of Affective Disorders, 172, 96–102.

Study type: Secondary analysis of a clinical cohortPopulation: 3,703 outpatients entering STAR*D with major depressive disorderDOI: 10.1016/j.jad.2014.10.010PMID: 25451401Last verified: 2026-08-31

WHAT THIS SOURCE SUPPORTS

Extensive symptom-profile heterogeneity within the studied STAR*D outpatient sample.

WHAT IT DOES NOT ESTABLISH

That major depression is 1,030 separate diseases, that diagnosis is useless or that a profile selects treatment.

Open original source ↗See this claim in context ↗

Lecture 48 · Section 35 · Mayberg’s Reciprocal Limbic - Cortical Model (1999)

Mayberg’s model changed the field by treating depression as a reciprocal circuit state that different interventions might perturb, while leaving efficacy to be established rather than assumed from the map.

Supported

KEY SOURCE · Historical or intellectual framing

Mayberg, H. S., Liotti, M., Brannan, S. K. et al. (1999). Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. American Journal of Psychiatry, 156(5), 675–682.

Study type: PET imaging comparison and circuit synthesisPopulation: People with depression and healthy participants studied during sadness and recovery conditionsDOI: 10.1176/ajp.156.5.675Last verified: 2026-08-31

WHAT THIS SOURCE SUPPORTS

An influential distributed, reciprocal circuit hypothesis linking limbic and cortical changes with sadness and depression.

WHAT IT DOES NOT ESTABLISH

A single-region cause, a diagnostic scan or efficacy of stimulating any one node.

Open original source ↗See this claim in context ↗

Lecture 48 · Section 38 · BROADEN 2017: The Sham-Trial Failure and What It Taught

BROADEN did not erase the early remissions; it established that mechanistic promise and open improvement were insufficient to prove that SCC-DBS itself outperformed sham.

Emerging

KEY SOURCE · Direct evidence

Mayberg, H. S., Lozano, A. M., Voon, V. et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45(5), 651–660.

Study type: Open-label proof-of-concept interventionPopulation: Six people with severe, highly treatment-resistant depressionDOI: 10.1016/j.neuron.2005.02.014PMID: 15748841Last verified: 2026-08-31

WHAT THIS SOURCE SUPPORTS

In an open six-person proof-of-concept study, four participants had sustained remission at six months.

WHAT IT DOES NOT ESTABLISH

A stable response rate, causal efficacy, superiority to sham or routine clinical effectiveness.

Open original source ↗See this claim in context ↗

KEY SOURCE · Direct evidence

Holtzheimer, P. E., Husain, M. M., Lisanby, S. H. et al. (2017). Subcallosal cingulate deep brain stimulation for treatment-resistant depression: A multisite, randomised, sham-controlled trial. The Lancet Psychiatry, 4(11), 839–849.

Study type: Multisite randomized sham-controlled trialPopulation: 90 implanted adults with treatment-resistant depressionDOI: 10.1016/S2215-0366(17)30371-1PMID: 28988904Last verified: 2026-08-31

WHAT THIS SOURCE SUPPORTS

In the six-month blinded phase, active SCC-DBS did not significantly outperform sham (about 20% versus 17% response), and the trial stopped for futility.

WHAT IT DOES NOT ESTABLISH

That no selected person can benefit, that all future targeting will fail or that early remissions were imaginary.

Open original source ↗See this claim in context ↗

REFERENCE INTELLIGENCE MAP

What each researcher contributed—and where Flow Hijacked goes beyond it.

Attribution does not imply endorsement of the project. It shows intellectual dependence and its limits.

#claim-depression-heterogeneity

Eiko I. Fried & Randolph M. Nesse

WHAT THIS SOURCE OR PERSON ACTUALLY ARGUES HERE: Made within-diagnosis symptom heterogeneity visible in STAR*D.
DIRECTNESS: Direct for the analyzed sample and symptom-profile definition.
DISAGREEMENT OR LIMIT: The result does not settle whether symptom-based, dimensional or categorical models should replace one another.
FLOW HIJACKED EXTENSION: Flow Hijacked uses heterogeneity to justify component-level reachability questions, not a new diagnostic count.

#claim-mayberg-circuit-model · #claim-broaden-correction

Helen S. Mayberg and colleagues

WHAT THIS SOURCE OR PERSON ACTUALLY ARGUES HERE: Developed the reciprocal circuit account and opened the SCC-DBS proof-of-possibility programme.
DIRECTNESS: Direct historical and mechanistic relevance; early efficacy evidence was uncontrolled.
DISAGREEMENT OR LIMIT: Anatomical relevance and dramatic early response do not by themselves establish treatment efficacy.
FLOW HIJACKED EXTENSION: The lecture treats BA25 as a case study in scientific power and self-correction, not as a depression switch.

#claim-broaden-correction

Paul E. Holtzheimer, Mustafa M. Husain, Sarah H. Lisanby and colleagues

WHAT THIS SOURCE OR PERSON ACTUALLY ARGUES HERE: Provided the decisive multisite randomized sham-controlled correction to the early open signal.
DIRECTNESS: Direct controlled evidence for the tested SCC-DBS protocol and population.
DISAGREEMENT OR LIMIT: The negative blinded phase constrains efficacy claims without proving that every future protocol or selected subgroup must fail.
FLOW HIJACKED EXTENSION: Flow Hijacked keeps the pilot and controlled trial together so possibility is never mistaken for efficacy.

CITATION & DOWNLOAD

Stable URL and downloadable bibliography

Avraham, Tomer. “Evidence map: Depression—When Reach Collapses.” Flow Hijacked. Verified 2026-08-31. https://flowhijacked.com/lectures/depression-when-reach-collapses/evidence

BibTeX ↓